How to Choose a Reliable IVD Manufacturer: A Practical Sourcing Guide for Diagnostic Companies

28Sep 2026

IVD Manufacturing IVDCDMO Team Comments: 0

How to Choose a Reliable IVD Manufacturer: A Practical Sourcing Guide for Diagnostic Companies

Choosing a reliable IVD manufacturer requires much more than comparing prices, certificates and product catalogs. In vitro diagnostic products directly influence clinical decisions, and seemingly small variations in raw materials, reagent formulation, manufacturing processes, calibration or storage conditions can affect analytical performance.

For diagnostic companies, distributors, laboratories and healthcare organizations sourcing internationally, the more useful question is therefore not simply:

“Does this supplier manufacture IVD products?”

It is:

“Can this manufacturer consistently produce the specific IVD product we need, at the required quality, scale and regulatory standard?”

That distinction is fundamental.

A credible supplier should be evaluated across several dimensions: regulatory readiness, quality management, technical competence, manufacturing capability, raw-material control, analytical verification, traceability, scalability and post-market support.

This guide explains how professional buyers can systematically evaluate an IVD manufacturer before entering a long-term supply, OEM, ODM or CDMO relationship.

1. Start With the Product, Not the Factory

One of the most common sourcing mistakes is searching for a “good IVD factory” before clearly defining what the product must accomplish.

IVD manufacturing is highly specialized. A company experienced in lateral flow rapid tests is not automatically qualified to manufacture quantitative chemiluminescence assays. Likewise, expertise in clinical chemistry reagents does not necessarily translate into molecular diagnostics.

Before approaching manufacturers, create a basic Target Product Profile (TPP) or equivalent requirement document.

At minimum, define:

Requirement	Questions to Answer
Intended use	What condition, analyte or biomarker will the test detect?
Sample type	Serum, plasma, whole blood, urine, saliva, swab or another specimen?
Technology	Lateral flow, ELISA, CLIA, FIA, PCR, qPCR, chemistry, immunoturbidimetry?
Result	Qualitative, semi-quantitative or quantitative?
Performance	Required sensitivity, specificity, precision and measuring range?
Format	Manual kit, POCT cartridge or automated analyzer reagent?
Throughput	Tests per hour/day and expected annual volume?
Shelf life	12, 18, 24 months or another target?
Storage	Ambient, refrigerated or frozen?
Target market	EU, United States, Middle East, Latin America, Asia or multiple markets?
Commercial model	Finished product, private label, OEM, ODM, CDMO or technology transfer?

A manufacturer should be evaluated against these requirements rather than against a generic definition of a “good supplier.”

2. Verify the Manufacturer’s Quality Management System

For most professional IVD sourcing projects, the quality management system should be examined early.

ISO 13485:2016 is the internationally recognized quality-management-system standard for medical devices. It addresses quality-management requirements relevant to organizations involved in medical-device design and manufacturing. ISO confirmed the 2016 edition again in 2025, so it remains current.

However, possessing an ISO 13485 certificate should not automatically end your due diligence.

Verify the certificate itself

Check:

Legal manufacturer name
Manufacturing-site address
Certification body
Certificate number
Validity period
Scope of certification
Product categories covered

The scope matters.

A certificate covering one type of medical device should not automatically be interpreted as evidence that every diagnostic product offered by the company falls within the same certified activities.

Look beyond the certificate

A functioning quality system should leave operational evidence.

Depending on the relationship and level of due diligence, buyers may investigate areas such as:

Document control
Supplier qualification
Incoming inspection
Production records
Equipment calibration
Nonconforming product control
CAPA
Complaint handling
Change control
Training records
Batch release
Traceability
Risk management

The objective is not to collect certificates.

The objective is to determine whether quality controls actually operate throughout the product lifecycle.

3. Match Regulatory Capability to Your Target Market

There is no universal regulatory credential that makes an IVD manufacturer suitable for every country.

Regulatory requirements depend on the product, intended use, risk classification and target jurisdiction.

European Union

For products intended for the EU, buyers should assess the manufacturer’s ability to operate within the requirements of the EU In Vitro Diagnostic Medical Devices Regulation (IVDR).

The European Commission emphasizes that manufacturers are responsible for bringing compliant IVDs to the European market, while IVDR places increased emphasis on risk classification, notified-body oversight where applicable, clinical evidence and lifecycle/post-market surveillance.

Therefore, asking only:

“Do you have CE?”

is often inadequate.

A more meaningful investigation examines the specific device, its regulatory status, applicable conformity-assessment route and supporting documentation.

United States

For the United States, buyers should understand the regulatory status of the specific product rather than treating FDA establishment registration as equivalent to product authorization.

FDA explicitly states that establishment registration does not constitute approval of an establishment or authorization of its products. Device listing likewise does not by itself establish that a device is legally authorized for U.S. marketing.

This distinction is extremely important in international sourcing.

Important 2026 change: FDA QMSR

As of February 2, 2026, FDA’s Quality Management System Regulation became effective. The revised 21 CFR Part 820 incorporates ISO 13485:2016 by reference, while retaining additional applicable FDA requirements.

For U.S.-oriented projects, supplier assessments should therefore reflect the current QMSR framework rather than relying solely on historical references to the former Quality System Regulation.

4. Evaluate Real Technical Competence

A reliable IVD manufacturer should understand the underlying assay—not merely know how to assemble and package the final kit.

This becomes particularly important for OEM, ODM and CDMO projects.

For an immunodiagnostic product, for example, technical competence may involve:

Antibody-pair selection
Antigen design
Conjugation chemistry
Blocking systems
Buffer formulation
Membrane selection
Calibration
Signal optimization
Interference reduction

For molecular diagnostics, capabilities may include:

Target selection
Primer/probe design
Enzyme systems
Extraction compatibility
Internal controls
Multiplex optimization
Contamination control
Amplification efficiency

For clinical chemistry:

Enzyme stabilization
Reagent formulation
Calibration
Linearity optimization
Interference studies
Analyzer adaptation

This leads to a useful sourcing principle:

Evaluate the technical team behind the product, not just the product catalog in front of you.

A large catalog can indicate commercial reach, but it does not by itself prove deep development capability.

5. Determine Whether the Manufacturer Controls Critical Raw Materials

IVD performance often depends heavily on biological and chemical raw materials.

These can include:

Antibodies
Antigens
Enzymes
Primers and probes
Calibrators
Controls
Membranes
Fluorescent particles
Magnetic beads
Latex particles
Substrates
Buffers and stabilizers

Ask where critical materials come from and how suppliers are qualified.

Important questions include:

Is there more than one qualified source for critical materials?

How is incoming material inspected?

How is lot-to-lot variation evaluated?

What happens if a critical antibody or enzyme becomes unavailable?

Does changing a raw-material supplier trigger formal change control and appropriate verification?

This becomes especially important for long-term OEM relationships.

A diagnostic kit may perform well today yet become commercially unreliable if its supply chain cannot reproduce the same critical materials three years later.

6. Ask for Evidence of Analytical Performance

Professional supplier qualification should move beyond statements such as:

“High sensitivity.”

“Excellent accuracy.”

“Reliable results.”

These are marketing descriptions, not sufficient analytical evidence.

Depending on the assay type and intended use, relevant performance characteristics may include:

Analytical sensitivity
Limit of detection
Analytical specificity
Precision
Repeatability
Reproducibility
Linearity
Measuring range
Interference
Cross-reactivity
Carryover
Hook effect
Cutoff determination
Method comparison

Not every parameter applies to every assay.

The important principle is that claimed performance should be supported by appropriately designed evidence.

7. Examine Lot-to-Lot Consistency

A prototype working correctly is only the beginning.

Commercial diagnostics require repeatable performance across manufacturing batches.

Consider asking the manufacturer how it demonstrates consistency across:

Raw-material lots → Intermediate products → Finished reagent lots → Final released kits

For quantitative assays, reviewing QC results across multiple production lots can be particularly informative.

The question buyers should ask is not:

“Can you make this product?”

but:

“Can you repeatedly make substantially the same product within defined acceptance criteria?”

That is a much higher manufacturing standard.

8. Evaluate Manufacturing Capacity—but Do Not Be Distracted by Factory Size

Factory photographs are useful but can easily become misleading.

A large facility does not automatically indicate superior IVD manufacturing.

What matters more is whether the facility has the right processes, equipment, controls and capacity for your particular product.

Evaluate:

Production-line configuration
Environmental requirements
Critical equipment
Automation level
Process controls
QC laboratory capabilities
Calibration and maintenance
Current utilization
Maximum practical capacity
Batch sizes
Lead times
Expansion capability

Capacity claims should also be interpreted carefully.

A factory theoretically capable of producing 10 million tests per month may not have that capacity available to your project.

Ask about available capacity, not merely installed capacity.

9. Understand the Difference Between R&D Samples and Commercial Manufacturing

This distinction is especially important in custom IVD development.

An experienced scientist may successfully produce 100 test strips manually.

That does not prove that the same formulation can be reliably manufactured as 100,000 tests.

Scaling introduces new variables:

Mixing volumes
Coating uniformity
Drying conditions
Dispensing accuracy
Environmental exposure
Equipment differences
Assembly tolerances
Packaging
Operator variation
Material consumption
Yield

For custom projects, ask how the manufacturer handles:

Prototype → Engineering batch → Pilot batch → Validation batch → Commercial production

Manufacturability should be considered during development rather than after development has supposedly finished.

10. Review Stability Data Carefully

Shelf life has direct commercial consequences.

A 24-month shelf life, for example, affects inventory planning, international shipping, distributor stock and usable selling time.

Ask how the claimed shelf life was established.

Depending on the product and development stage, stability programs may involve:

Real-time stability
Accelerated stability
Open-vial stability
In-use stability
Transport simulation
Freeze-thaw studies
Temperature excursions

Accelerated testing can provide valuable development information, but buyers should understand the basis for the manufacturer’s final shelf-life claim and what supporting data are available.

Also examine packaging.

For many IVD products, moisture, oxygen, light and temperature exposure can be as important as the reagent formulation itself.

11. Investigate Traceability

Imagine discovering a performance problem six months after importing 50,000 tests.

Can the manufacturer determine:

Which finished batch was affected?
Which raw-material lots were used?
When it was produced?
Which production line was involved?
Which QC results were recorded?
Which customers received related batches?
Whether other lots may be affected?

This is where traceability becomes commercially important.

A strong traceability system makes investigation, containment and corrective action possible.

Without it, a relatively narrow batch problem can become a much larger supply-chain problem.

12. Evaluate Change Control

Change control is one of the most underestimated factors in supplier selection.

During a multi-year supply relationship, changes are inevitable.

A manufacturer may change:

Raw-material supplier
Antibody lot
Formulation
Equipment
Production process
Packaging material
Software
Labeling
Manufacturing location

The critical issue is whether these changes are controlled, assessed, documented and communicated when required.

Buyers should establish contractual expectations regarding significant changes before commercial supply begins.

Otherwise, a product you validated in Year 1 may not be technically identical to the product being supplied in Year 3.

13. Assess OEM, ODM and CDMO Capabilities Separately

Not every manufacturer needs to be a CDMO.

The appropriate capability depends on your project.

Model	Manufacturer’s Primary Role	Appropriate When
Private Label	Existing product with customized branding	Fast market entry
OEM	Manufacture to defined specifications	Buyer already controls product design
ODM	Product design/adaptation + manufacturing	Product customization is required
CDMO	Development + scale-up + manufacturing	New or technically differentiated product
Technology Transfer	Development/process transferred to buyer	Buyer intends to manufacture locally

A company that is excellent at producing an established rapid test may not necessarily have the R&D infrastructure required for a novel CDMO project.

Likewise, paying for extensive development capabilities may be unnecessary if you simply need private-label supply of an established product.

14. Audit the Manufacturer When the Risk Justifies It

For important projects, document review should eventually be complemented by an audit.

This can be performed:

On-site
Remotely
Through an independent third-party auditor

The depth of the audit should be proportionate to product and supplier risk.

Potential audit areas include:

Quality management
Warehouse controls
Incoming inspection
Production processes
Environmental controls
QC laboratory
Batch records
Equipment management
CAPA
Complaint handling
Supplier management
Traceability
Change control

The purpose of an audit is not to find a perfectly clean factory.

It is to understand whether the manufacturer has a functioning system capable of identifying, documenting and controlling problems.

15. Do Not Select an IVD Manufacturer on Price Alone

Unit price matters.

But purchase price and total sourcing cost are different things.

Consider the potential cost of:

Failed incoming inspection
Rejected batches
Delayed shipments
Short shelf life
Regulatory documentation gaps
Customer complaints
Product recalls
Revalidation after undocumented changes
Lost tenders
Distributor disputes
Emergency replacement inventory

A slightly cheaper kit can become significantly more expensive when quality problems appear after international distribution.

This does not mean the most expensive manufacturer is the best.

It means price should be evaluated after minimum technical, quality and regulatory requirements have been satisfied.

16. Red Flags When Evaluating an IVD Manufacturer

No single warning sign automatically proves that a supplier is unreliable. Several occurring together, however, justify deeper investigation.

Be cautious when a manufacturer:

Cannot clearly identify the legal manufacturing entity
Provides certificates that cannot be independently verified
Avoids questions about critical raw materials
Cannot explain batch-release criteria
Makes regulatory claims without identifying the specific product
Treats FDA registration as equivalent to FDA product authorization
Provides only marketing brochures instead of performance evidence
Cannot explain how complaints and CAPA are handled
Cannot provide basic lot traceability
Changes important components without documented control
Claims unrealistically broad technical capabilities without supporting evidence
Refuses reasonable audit or documentation requests without explanation

One particularly useful signal is technical transparency.

Experienced manufacturers generally understand that sophisticated buyers will ask difficult questions.

17. A Practical IVD Manufacturer Evaluation Framework

A supplier evaluation can be organized into six dimensions:

A. Regulatory Fit

Can the manufacturer support the regulatory requirements of the specific product and destination market?

B. Quality System

Does the manufacturer operate an appropriate, documented and functioning quality-management system?

C. Technical Capability

Does its R&D and engineering team understand the assay technology involved?

D. Manufacturing Capability

Can the process be reproduced consistently at the required commercial scale?

E. Supply-Chain Reliability

Can critical raw materials and production capacity be maintained over the expected product lifecycle?

F. Commercial Support

Can the supplier provide appropriate documentation, communication, change notification, technical support and post-market cooperation?

Only after these areas have been evaluated does a meaningful price comparison become possible.

18. Questions to Ask Before Choosing an IVD Manufacturer

A useful first-round supplier questionnaire might include:

What is the legal name and address of the actual manufacturing entity?
Which products are manufactured at this facility?
What quality-management certifications does the facility hold?
What is the exact scope and validity of those certifications?
What regulatory status does the specific product have in our target market?
Which critical raw materials are manufactured internally and which are externally sourced?
How are critical suppliers qualified?
What analytical performance data are available?
How is lot-to-lot consistency monitored?
What stability data support the stated shelf life?
What are the standard batch size and production lead time?
How are finished products released?
What traceability records are maintained?
How are customer complaints investigated?
How are CAPA activities managed?
How are significant product or process changes controlled and communicated?
Can we conduct a factory audit?
Can you support pilot production before commercial orders?
What technical documentation can be provided?
What happens if a critical raw material becomes unavailable?

The quality of the answers can reveal almost as much as the answers themselves.

How IVD CDMO Can Support Manufacturer Sourcing

Finding an IVD manufacturer through an online search is relatively easy.

Determining whether that manufacturer is appropriate for a specific diagnostic project is much more difficult.

IVD CDMO is a specialized platform designed to connect international diagnostic buyers and project owners with manufacturers, development organizations and supply-chain resources across the IVD industry.

Projects may involve areas such as:

Rapid diagnostic tests
Lateral flow assays
ELISA
CLIA
Fluorescence immunoassays
Clinical chemistry
Molecular diagnostics
PCR and qPCR
Diagnostic instruments
Antibodies and antigens
Diagnostic enzymes and raw materials
OEM and ODM manufacturing
Custom test kit development
CDMO services
Technology transfer

The platform approach is particularly useful when sourcing requirements extend beyond finding a product catalog and require matching product technology, manufacturing capability, regulatory requirements and commercial objectives.

Frequently Asked Questions

What certifications should a reliable IVD manufacturer have?

There is no single certificate that proves universal suitability. ISO 13485 is an important internationally recognized medical-device quality-management standard, but buyers should also evaluate its scope, the specific product’s regulatory requirements and the requirements of the destination market.

Does FDA registration mean an IVD manufacturer is FDA approved?

No. FDA states that establishment registration does not constitute approval of the establishment or its devices. Product-specific regulatory status should be verified separately.

Is ISO 13485 enough to qualify an IVD supplier?

Not by itself. ISO 13485 provides an important quality-management framework, but supplier qualification should also examine product-specific technical competence, manufacturing processes, analytical performance, regulatory fit, traceability and supply-chain controls.

Should I audit an IVD factory before ordering?

For higher-risk products, large-volume purchases or strategic OEM/CDMO relationships, an appropriately scoped supplier audit can provide information that certificates and questionnaires alone cannot.

What is the difference between an IVD manufacturer and an IVD CDMO?

A conventional manufacturer may primarily manufacture established products. An IVD CDMO typically provides a broader development pathway that can include feasibility studies, assay development, formulation, optimization, pilot production, scale-up and commercial manufacturing.

How can I verify an IVD manufacturer’s quality claims?

Start with primary evidence: certificates and their issuing bodies, product-specific regulatory records where applicable, analytical reports, manufacturing documentation, stability evidence, samples, batch records and audits. Avoid relying exclusively on website claims or sales presentations.

Conclusion: Choose an IVD Manufacturing System, Not Just a Supplier

The most reliable IVD manufacturer is not necessarily the company with the largest factory, longest product catalog, lowest quotation or most certificates displayed on its website.

Professional supplier selection requires a more systematic approach.

Start with the intended product and market. Verify the quality system. Examine product-specific regulatory status. Evaluate the technical team. Understand critical raw materials. Review analytical and stability evidence. Investigate manufacturing scalability, lot consistency, traceability and change control. Finally, confirm that the commercial relationship can remain reliable throughout the product lifecycle.

The objective is not simply to find a factory capable of producing an IVD test today.

It is to identify a manufacturing partner capable of consistently delivering the required product, at the required quality, under the required regulatory framework, over time.

For diagnostic companies sourcing internationally, that distinction can determine whether a promising IVD product becomes a sustainable commercial product—or a recurring supply-chain problem.

Author Profile

IVDCDMO Team: Written by the IVDCDMO technical and regulatory team, with expertise in diagnostic assay development, GMP manufacturing, ISO 13485 systems, and global IVD commercialization for biotech innovators worldwide.